相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Platinum(iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance
Qiling Chen et al.
CHEMICAL COMMUNICATIONS (2018)
Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity
Frederick Y. K. Siu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Mediterranean essential oils as precious matrix components and active ingredients of lipid nanoparticles
C. Carbone et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Resveratrol-loaded nanoparticles conjugated with kidney injury molecule-1 as a drug delivery system for potential use in chronic kidney disease
Yuh-Feng Lin et al.
NANOMEDICINE (2017)
Alternative treatment methods attenuate the development of NAFLD: A review of resveratrol molecular mechanisms and clinical trials
Tomasz Charytoniuk et al.
NUTRITION (2017)
A comprehensive review of the health perspectives of resveratrol
Abdur Rauf et al.
FOOD & FUNCTION (2017)
PLGA nanoparticles for the oral delivery of nuciferine: preparation, physicochemical characterization and in vitro/in vivo studies
Ying Liu et al.
DRUG DELIVERY (2017)
New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity
Hangxiang Wang et al.
CANCER RESEARCH (2017)
Antiobesity effects of resveratrol: which tissues are involved?
Alfredo Fernandez-Quintela et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2017)
Resveratrol and diabetes: A critical review of clinical studies
Ebru Ozturk et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
The therapeutic potential of resveratrol: a review of clinical trials
Adi Y. Berman et al.
NPJ PRECISION ONCOLOGY (2017)
Effects of Fatty Acids on CYP2A5 and Nrf2 Expression in Mouse Primary Hepatocytes
Yizhe Cui et al.
BIOCHEMICAL GENETICS (2016)
Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy
Zhongjian Chen et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
Sara Heeboll et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2016)
Resveratrol loaded PLGA: D-alpha-tocopheryl polyethylene glycol 1000 succinate blend nanoparticles for brain cancer therapy
Mahalingam Rajamanickam Vijayakumar et al.
RSC ADVANCES (2016)
Formulation, characterization and evaluation of cyclodextrin-complexed bendamustine-encapsulated PLGA nanospheres for sustained delivery in cancer treatment
Bina Gidwani et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2016)
Stability and solubility of trans-resveratrol are strongly influenced by pH and temperature
Spela Zupancic et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Glucocorticoids and non-alcoholic fatty liver disease
Conor P. Woods et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway
Yong Zhang et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2015)
Effect of resveratrol on experimental non-alcoholic steatohepatitis
Sara Heeboll et al.
PHARMACOLOGICAL RESEARCH (2015)
Microencapsulation of coupled folate and chitosan nanoparticles for targeted delivery of combination drugs to colon
Puwang Li et al.
JOURNAL OF MICROENCAPSULATION (2015)
New Perspective in the Formulation and Characterization of Didodecyldimethylammonium Bromide (DMAB) Stabilized Poly(Lactic-co-Glycolic Acid) (PLGA) Nanoparticles
Rebecca Gossmann et al.
PLOS ONE (2015)
PLGA: a unique polymer for drug delivery
Deepak N. Kapoor et al.
THERAPEUTIC DELIVERY (2015)
ATR-FTIR spectroscopy as a tool to probe surface adsorption on nanoparticles at the liquid-solid interface in environmentally and biologically relevant media
Imali A. Mudunkotuwa et al.
ANALYST (2014)
Protective effect of resveratrol derivatives on high-fat diet induced fatty liver by activating AMP-activated protein kinase
You-Jin Choi et al.
ARCHIVES OF PHARMACAL RESEARCH (2014)
Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
Veronique S. Chachay et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Exploring the potential of self-assembled mixed micelles in enhancing the stability and oral bioavailability of an acid-labile drug
Xingwang Zhang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Optimized PLGA nanoparticle platform for orally dosed trans-resveratrol with enhanced bioavailability potential
Gurinder Singh et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
Chemistry, Stability and Bioavailability of Resveratrol
Antonio Francioso et al.
MEDICINAL CHEMISTRY (2014)
NAFLD, NASH and liver cancer
Gregory A. Michelotti et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Hepatocellular Proliferation Correlates with Inflammatory Cell and Cytokine Changes in a Murine Model of Nonalchoholic Fatty Liver Disease
Michael N. VanSaun et al.
PLOS ONE (2013)
Non-alcoholic fatty liver disease and liver transplantation: Outcomes and advances
Adnan Said
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Melanie D. Beaton
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
Kenneth Cusi
GASTROENTEROLOGY (2012)
Development and evaluation of sustained-release clonidine-loaded PLGA microparticles
Amelie Gaignaux et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
The Role of Nutrients in the Development, Progression, and Treatment of Nonalcoholic Fatty Liver Disease
Marialena Mouzaki et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
PLGA-based nanoparticles: An overview of biomedical applications
Fabienne Danhier et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions
Pietro Vajro et al.
ITALIAN JOURNAL OF PEDIATRICS (2012)
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Hirenkumar K. Makadia et al.
POLYMERS (2011)
Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ε-caprolactone) nanoparticles: In vitro and in vivo evaluation
Hongliang Xin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis
Detlef Schuppan et al.
LIVER INTERNATIONAL (2010)
Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: Formulation, optimization and in vitro characterization
Zhang Wei et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Effect of acidic pH on PLGA microsphere degradation and release
Banu S. Zolnik et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Elevated temperature accelerated release testing of PLGA microspheres
Banu S. Zolnik et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Development of a sustained-release system for perivascular delivery of dipyridamole
WW Zhu et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS (2006)
Involvement of mtDNA damage in free fatty acid-induced apoptosis
V Grishko et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology
S Freitas et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Controlled release of dexamethasone from PLGA microspheres embedded within polyacid-containing PVA hydrogels
I Galeska et al.
AAPS JOURNAL (2005)
Mathematical modeling of bioerodible, polymeric drug delivery systems
J Siepmann et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
A novel mouse model of lipotoxic cardiomyopathy
HC Chiu et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres
K Fu et al.
PHARMACEUTICAL RESEARCH (2000)
分享论文
